ACR246, a first in next-generation 5T4-ADC, as a potential choice of treating 5T4-positive solid tumors.
Year: 2025
Type: article
Source: Journal of Clinical Oncology
Authors: Xi Jiao, Zhenwei Miao, Jing Gao, Yunsheng Huang, Feng Wang, Yaowu Li, Li Yang, Shanhui Weng, Lin Shen
Institution: Peking University Cancer Hospital
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410815726